BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14679674)

  • 41. Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients).
    Tóth K;
    Am J Cardiovasc Drugs; 2014 Apr; 14(2):137-45. PubMed ID: 24590580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry.
    Libhaber EN; Libhaber CD; Candy GP; Sliwa K; Kachope J; Hlatshwayo NM; Puane MO; Woodiwiss AJ; Norton GR; Essop MR; Sareli P
    Am J Hypertens; 2004 May; 17(5 Pt 1):428-32. PubMed ID: 15110902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
    Laurent S
    J Hypertens Suppl; 2001 Nov; 19(4):S9-14. PubMed ID: 11848262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension.
    Kang S; Wu YF; An N; Ren M
    Clin Ther; 2004 Feb; 26(2):257-70. PubMed ID: 15038948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Americans demand stricter blood pressure control. Does 120/80 already need to be treated?].
    Holzgreve H
    MMW Fortschr Med; 2003 May; 145(22):15. PubMed ID: 12866266
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
    Tzourio C; Anderson C; Chapman N; Woodward M; Neal B; MacMahon S; Chalmers J;
    Arch Intern Med; 2003 May; 163(9):1069-75. PubMed ID: 12742805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
    Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
    Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fixed dose combination perindopril-indapamide-amlodipine (Triplixam) for the treatment of arterial hypertension].
    Scheen AJ; Lancellotti P; Krzesinski JM
    Rev Med Liege; 2014 Oct; 69(10):565-70. PubMed ID: 25796752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration.
    Joannides R; Bellien J; Thurlure C; Iacob M; Abeel M; Thuillez C
    Am J Hypertens; 2008 Jun; 21(6):679-84. PubMed ID: 18443573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programme.
    Pella D
    High Blood Press Cardiovasc Prev; 2011 Sep; 18(3):107-13. PubMed ID: 21950782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension.
    de Leeuw PW; ;
    J Hypertens Suppl; 2001 Sep; 19(3):S41-5. PubMed ID: 11713850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Arterial hypertension in elderly individuals].
    Ambrosioni E
    Presse Med; 2002 Oct; 31 Spec No 2():S17-20. PubMed ID: 12356000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Old or new antihypertensives--which are better?].
    Schrader J; Kulschewski A
    MMW Fortschr Med; 2005 Mar; 147(13):36-7, 39-40. PubMed ID: 15832760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.
    Mourad JJ; Lameira D; Guillausseau PJ
    Vasc Health Risk Manag; 2008; 4(2):443-51. PubMed ID: 18561520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ADVANCE: breaking new ground in type 2 diabetes.
    Chalmers J; Perkovic V; Joshi R; Patel A
    J Hypertens Suppl; 2006 Aug; 24(5):S22-8. PubMed ID: 16936533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected].
    Ghiadoni L
    Expert Opin Pharmacother; 2010 Jul; 11(10):1647-57. PubMed ID: 20518617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.